FDA advises of updated Trasylol labelling

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1133卷 / 1期

关键词：

Blood Transfusion; Operative Setting; Coronary Artery Bypass Grafting; Artery Bypass; Renal Dysfunction;

D O I：

10.2165/00128415-200711330-00002

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[21] FDA advises against using Venom Hyperdrive 3.0
[J]. Reactions Weekly, 2009, 1238 (1) : 2 - 2
[22] IOM Advises FDA on Ethics in Postmarket Safety Trials
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (06): : 627 - 627
[23] FDA advises drug sponsors on supplemental drug applications
不详
[J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2003, 222 (01): : 10 - 10
[24] Labelling updated for mycophenolic acid
[J]. Reactions Weekly, 2009, 1269 (1) : 2 - 2
[25] Ketek labelling updated in Canada
[J]. Reactions Weekly, 2007, 1169 (1) : 6 - 6
[26] US Erbitux labelling updated
[J]. Reactions Weekly, 2005, 1070 (1) : 2 - 2
[27] Celecoxib labelling updated in the US
[J]. Reactions Weekly, 2002, 908 (1) : 2 - 2
[28] Sensipar labelling updated in Canada
[J]. Reactions Weekly, 2007, 1159 (1) : 3 - 3
[29] Champix labelling updated in Canada
[J]. Reactions Weekly, 2010, 1305 (1) : 2 - 2
[30] Tequin: labelling updated in Canada
[J]. Reactions Weekly, 2006, 1103 (1) : 3 - 3

← 1 2 3 4 5 →